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Abstract: The purpose of this retrospective study is to compare the short-term clinical and radiological
results between standard and dual mobility THA for femoral neck fractures (FNF) in older patients.
The hypothesis is that the dual mobility cup (DMC) has the same outcomes but a lower dislocation
rate than the standard THA. The study population included 56 patients (mean age 77.7 years, range
71–85) that underwent THA for displaced FNF. Patients were divided in two comparable groups for
baseline characteristics (age, sex and comorbidities): 28 patients underwent THA with a standard cup
(SC) and 28 THA with DMCs. The clinical records and radiograms were reviewed to search relevant
data in their postoperative history. Two postoperative dislocations occurred in the SC group and none
in the DMC group. At an average follow up of 23 months (12–40), 48 patients were available for the
final evaluation. The WOMAC score for all patients averaged 6.26 (0–46) and was slightly better in the
DMC group (4.94 vs. 7.58; p-value = 0.41); scores were significantly better in presence of neurological
comorbidities (p-value = 0.04), in the absence of diabetes (p-value = 0.04) and in the case of psychiatric
disorders (p-value = 0.02). Radiographic evaluation at one year showed signs of osteointegration in
42/48 (87.5%) acetabular components (20 DMCs, 22 SC). According to our experience, DMCs proved
to be a valid option for the treatment of displaced FNF in older patients, since it allowed them to
achieve short-term outcomes comparable to conventional THA, while decreasing the incidence of
postoperative dislocations.
Keywords: dual mobility cup; total hip arthroplasty; femoral neck fracture; dislocation; elderly
patients
1. Introduction
Dislocation is one of the most frequent complications of total hip arthroplasty (THA),
with an incidence of 0.2–10% in primary surgery [1,2] and up to 28% in revision cases [3,4].
It is still the first reason for early THA revision and the second reason for revision at any
time [5–8]. Particularly, dislocation is the most frequent complication when THA is per-
formed to treat displaced fractures of the femoral neck [9]. Dislocation increases mortality
in elderly patients undergoing THA, with a mortality rate of 65% compared to 10% without
this complication [10]. THA instability has a multifactorial etiology, and its treatment might
be challenging. Patient-related risk factors include old age, female gender, previous hip
surgery, neurological diseases (e.g., dementia and Alzheimer’s), neuro-muscular diseases
(e.g., Parkinson’s, stroke sequelae and myopathies), spino-pelvic abnormalities (e.g., previ-
ous spinal disorders and surgery), cognitive impairment during hospitalization and the
pathology for which surgery is indicated, namely hip fractures [11,12].
Different design solutions have been proposed and adopted to decrease the risk of
instability: liner augmentation wedges, angle-bore acetabular components, jumbo heads
and constrained liners have been used with limited success.
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Nowadays, there is increasing interest in dual mobility cups (DMCs) as an effective
system to prevent dislocations in THA. DMCs are characterized by a mobile polyethylene
liner, providing a double articular interface between a small head and the liner, and between
the liner and a metallic acetabular cup, ensuring greater range of motion and decreasing
the risk of dislocation. The first model of DMC was developed in France by Bousquet in
1974. DMCs have been used in Europe for more than 40 years, while the FDA approved
their use in the USA only in 2009.
The aim of this study is to compare the short-term clinical and radiological outcomes
between standard and DMC total hip replacements in two groups of patients treated
for femoral neck fractures (FNF). The hypothesis is that DMC implants have the same
outcomes but a lower dislocation rate in comparison to standard implants.
2. Materials and Methods
This retrospective, single-center study was performed on a series of 56 patients treated
with THA for FNF in a three-year period (January 2017–December 2019). Half of the
patients underwent THA with an uncemented standard unipolar cup (TMT®, Zimmer
Biomet, Warsaw, IN, USA) with a 10◦ polyethylene liner augmentation wedge (SC group),
while an uncemented DMC (Dualis®, Bioimpianti, Peschiera Borromeo, Italy) was used in
the remaining 28 patients (DMC group). A cemented femoral stem was used in all patients
(Versys Heritage®, Zimmer Biomet for SC group; Korus®, Bioimpianti for DMC group). In
the SC group, a 32 mm metallic femoral head was used, while DMCs were coupled with a
28 mm ceramic head.
Preoperative planning was performed on digital radiograms of the contralateral hip
with the use of OrthoView software for Carestream PACS (Carestream Health, Rochester,
NY, USA).
All the procedures were performed through a postero-lateral approach, with reattach-
ment of the short external rotators. A double administration of vancomycin was used for
antibiotic prophylaxis: 1 g preoperatively and 0.5 g 12 h after surgery.
In-hospital rehabilitation was started the first day after surgery and patients were
mobilized out of bed on day 2 for gait re-education with a walking frame.
After discharge from the hospital, patients were evaluated clinically and radiographi-
cally at 1, 3, 6 and 12 months after surgery. At the last follow up, the WOMAC osteoarthritis
index [13] was recorded.
Acetabular osteointegration was analyzed on X-rays using the Moore criteria [14]: the
presence of the three most sensitive signs (absence of radiolucent lines, presence of supero-
lateral buttress and presence of medial stress-shielding) defined the cup as “osteointegrated”.
Statistical analysis was performed with STATA 13 software (StataCorp LLC, College
Station, TX, USA). The scores were compared with the use of a paired Student’s t-test for
parametric data and with the use of Wilcoxon–Mann–Whitney test for non-parametric data.
The significant cut-off for the p-value was set to 0.05. We compared the two groups for
demographic data, comorbidities, length of stay from surgery to discharge, dislocation
and infection rate, osteointegration, heterotopic ossification and WOMAC score. We also
investigated correlations between WOMAC and each variable in both groups and in the
total population of the study.
3. Results
At an average follow up of 23 months (range, 12 to 40), 48 patients were evaluated
with the WOMAC score. Eight patients (four in each group) died for reasons not related to
surgery before the last follow up: no postoperative complications were recorded among
these patients, who were eventually excluded for further analyses. Thus, 24 patients for
each group were included in the study and fully assessed.
Demographic and relevant clinical data of the patients are reported in Table 1. The
two groups of patients were comparable for age and gender. The analysis of comorbidities
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revealed a statistically significant prevalence of neurologic comorbidities and psychiatric
disorder in DMC group.
Table 1. Demographic and relevant clinical data of the study population.
DMC Group n = 24 SC Group n = 24 p-Value
Age 77.03 78.35 0.41
Gender (M:F) 7:21 7:21 1.00
Neurological comorbidities (1) 12 4 0.03 *
Diabetes 0 3 0.23
Obesity 5 2 0.41
Rheumatological diseases 2 2 0.99
Psychiatric disorders (2) 6 0 0.02 *
(1) Parkinson’s disease n = 3/1; Hemiplegia n = 1/0; Hemiparesis n =8/3. (2) Anxiety-depressive disorder n = 6/0.
(*) statistically significant p-values.
The mean length of hospital stay was 8.14 days (SD ± 3.18) for the DMC group and 7.75
(SD ± 3.19) for the SC group; the difference was not statistically significant (p-value = 0.64).
No dislocation occurred in the DMC group, while two dislocations were observed
in the SC group. Both dislocations occurred during the first month after surgery: one
in a male patient following an accidental fall and one in a female patient without any
traumatic event. The first patient was treated with closed reduction and THA dislocation
never recurred. The female patient suffered of postoperative moderate-grade delirium
with poor cooperation in the rehabilitation program; dislocation occurred twice in the
rehabilitation institute. In consideration of her mental state and poor compliance, she
underwent a revision procedure: the femoral stem and acetabular cup were retained, the
liner and the head were substituted and a neck adapter (Bioball®, Merete GmbH, Berlin,
Germany) was implanted to increase length and lateral offset in order to enhance implant
stability (Figure 1). Dislocation did not recur and at follow up the patient reported complete
recovery of autonomy and preoperative activities.
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Fig re 1. (a) Displaced intr capsular fracture (Garden-type IV) of the right femoral neck in a
79-year-old woman. (b) Postoperative radiograph after surgical treatment with a conventional THA.
(c) Prosthesis dislocation 3 weeks after surgery. (d) Radiograph after implantation of a neck adaptor
to increase length and lateral offset.
No other complications, such as infections or mechanical failures, were observed in
this series of patients.
At follow up, the mean WOMAC score for all patients was 6.26 (range, 0–46). The
score in the DMC group was better (lower) than in the SC group: 4.94 (SD ± 9.12) vs. 7.58
(SD ± 12.5). However, the difference was not statistically significant (p-value = 0.41).
Radiographic signs of acetabular osteointegration at 1 year (Figure 2) were found in
42 patients (87.5%): 20 in the DMC group (83.3%) and 22 in the SC group (91.6%), with a
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non-significant difference (p-value = 0.98). No cases of implant mobilization were detected
on X-rays. Heterotopic ossifications had a similar incidence in the two groups: four in the
DMC group and three in the SC group (p-value = 0.99).
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4. Discussion
The dual mobility concept was developed by Bousquet 50 years ag to decrease the
risk of THA dislocation. In standard THA, it was demonstrated that head sizes larger
than 36 mm increase the head/neck ratio and the “jumping” distance. Consequently,
impingement between neck and the liner rim is reduced and hip stability is increased [15].
The presence of two distinct articulations in the DMC combines Charnley’s principle of low
friction arthroplasty with the McKee–Farrar concept of larger femoral heads to enhance
stability: primary movement occurs at the inner bearing, while the outer bearing only
moves at the extreme ranges of movement [16]. Owing to these features, the use of DMCs
for the treatment of FNF has increased exponentially in the last decade [17].
Geriatrics 2021, 6, 70 5 of 9
Several trials comparing THA and hemiarthroplasty (HA) for the treatment of FNF
showed better functional outcomes and lower re-operation rates for THA, but also a higher
incidence of dislocations [18,19]. In literature, good results with DMC implants were
reported in either FNF [20–22] or other conditions at increased risk for dislocation [10].
However, there are few retrospective and some register studies comparing DMC THA and
standard THA in FNF [17,23–25], despite it being known that THA for fractures has a higher
risk of dislocation than THA for osteoarthritis [26–28]. This risk could be related to different
predisposing conditions observed in FNF patients, such as a good preoperative hip ROM,
the prevalence of recurrent falls in older patients or the frequent postoperative delirium
that compromises adherence to rehabilitation programs [29,30]. This increased risk is
further confirmed by some systematic reviews: the authors of [31] reported that DMC THA
is associated with a significantly lower dislocation rate compared with conventional THA
(OR 0.26; 95% CI, 0.08 to 0.79); this was also confirmed by Romagnoli M. et al. [32], who
showed a slight significant risk ratio of 0.16 (95% CI, 0.09, 0.28; I2 = 0%, p-value < 0.00001),
with a statistically significant difference between the two groups.
The one-year mortality rate after FNF reported in the literature ranges between 14%
and 36% [33–35]. This incidence is mainly influenced by patient-related factors, which
include age, systemic comorbidities, short-term complications and mental and motivational
states [36]. However, the quality of health care and the promptness of rehabilitation are
also critical factors to improve the prognosis of these patients. The mortality rate in this
series of patients (mean age 77.7 years) was 14.3% at one year, in accordance with the data
reported by Tarasevicius et al. in similar studies [23,24].
We reported a dislocation rate of 8.3% (2/24) in the SC group, while no dislocation
was observed in the DMC group. The difference did not reach a statistical significance,
probably because the sample size was too small. However, it is worth to underline that
patients affected by neuromuscular disease, such as Parkinson’s disease and hemiparesis
following a stroke, were statistically predominant in the DMC group. This observation
supports the use of DMCs in conditions with a higher risk of THA dislocation.
Tarasevicius et al. compared the results of 56 standard cups and 42 DMCs in a series
of 98 patients treated with THA for FNF [23]. All the procedures were performed through
a postero-lateral approach without any soft tissue repair. They reported a dislocation rate
of 14.2% for the standard cups, whereas no dislocations nor intraprosthetic dislocations
were reported in the DMC group; the difference was statistically significant.
Adam et al., in a multicentric study of 214 FNF patients treated with DMC THA,
reported a dislocation rate of 1.4% (3 cases). All dislocations were posterior and occurred
at the large articulation between the polyethylene liner and the metallic shell. They were
observed within 3 months from surgery and were uneventfully treated with close reduction
under general anesthesia. Poor anteversion of the cup at X-ray was noted in all these
patients, who were operated on through a posterior approach [20].
Recent register studies referred for DMC THA a lower risk of revision for dislocation
when compared to conventional THA [17,25].
Johansson et al. reported a dislocation rate of 22% in conventional THA performed
for FNF, driving the attention to the poor adherence of these patients to postoperative
prescriptions [37]. In the present series, one dislocation (standard cup) occurred in an
81-year-old woman, who lived alone and experienced postoperative delirium. The risk
should be carefully assessed when choosing the type of hip arthroplasty for FNF: when
THA is selected, a DMC implant seems to be more reliable in preventing dislocation for
older and non-compliant (e.g., cognitively impaired) patients.
For the treatment of FNF, some authors proposed to implant the DMC through the
Hueter’s anterior approach [38,39]. This surgical technique offers an additional protection
against early THA dislocations, as observed with bipolar hemiarthroplasty [40]. However,
there are some drawbacks for this approach when performed in older osteoporotic patients, in-
cluding a higher risk of intraoperative fractures and a more troublesome cementing technique.
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We did not observe any case of intraprosthetic dislocation (IPD) between the retentive
polyethylene liner and the prosthetic head, but a longer follow up is needed to exclude the
occurrence of this complication. IPD is a long-term complication of earlier dual mobility
implants, mainly related to implant wear at the retentive rim of the polyethylene liner.
Early sporadic IPD was also reported for newer implants, but they occurred after revision
procedures for THA dislocation [41,42] or were consequent to assembly errors, namely poor
impaction of the polyethylene inserts over the prosthetic head [21]. Tabori-Jensen et al., in
a consecutive series of 966 patients treated with DMC for FNF, referred a dislocation rate of
4.7%. They reported eight IPD: six occurred during an attempt of closed reduction and two
were related to a fall [43].
There are no conclusive data supporting the hypothesis that DMC are associated
with a higher risk of infection. It has been hypothesized that additional manipulative
maneuvers for impacting the head in the DMC liner might represent a potential source
for infection [44]. A cohort study, based on the Nordic Arthroplasty Register Association
(NARA) database, showed a higher risk of revision for infection for DMCs in primary THA
for osteoarthritis [45]. However, the authors highlighted that this finding could be related
to a selection bias, since DMCs were implanted in patients with greater frailty and therefore
with a baseline increased risk of infection [45]. Match cohort study and meta-analysis of
comparative study confuted this finding, reporting higher infection rates with the standard
cup than with the DMC in revision procedures [46,47]. Jobory et al., in another register
study from NARA database, matched 4520 hip fractures treated with DMCs to 4520 hip
fractures treated with conventional THA [25]. They concluded that DMC-treated patients
had a lower risk of revision in general including and no difference regarding revision for
infection. We did not detect any prosthetic infection in our small series of patients, with
two comparable groups for diabetes and obesity.
According to the WOMAC scores recorded (mean 6.26), the clinical outcome of the
patients included in this study was good, with a non-significant superiority in favor of
DMC patients. Better scores in patients with neurologic comorbidities and psychiatric
disorders, which were predominant in the DMC group, seem to validate the use of DMCs
in these conditions.
In a retrospective study, Fahad et al. compared DMC THA with bipolar HA for the
treatment of displaced FNF in a series of 99 patients (77 BHA, 22 DMC) with a mean
age of 70 years. At an average follow up of 20 months, better hip functional outcomes
were observed in the DMC group (mean Harris hip score of 76.8 vs. 68.8), while no
significant difference was noted in terms of postoperative surgical complications and one-
year mortality rate [48]. In a study comparing DMCs and conventional THA for FNF,
Tarasevicious et al. found no difference between the two groups of patients at any time
of follow up, considering any subscale of HOOS score, mobility, use of walking aids and
EQ-5D [48]. Adam et al., at the 9-month follow up of their multicentric study, observed that
70% of DMC-treated patients for FNF had returned home with no increase in dependency,
50% did not need any walking assistance at home and 31% were independent from walking
aids [20].
Radiographic examination did not reveal any complication at 1-year follow up, with a
rate of 87.5% (42/48) osteointegrated cups in the total population. The SC group showed
a higher number of osteointergrated cups than DMC (22 vs. 20), but this difference was
not significant. It must be noted that the DMCs used in our series did not allow for the
insertion of screws to increase primary stability of the acetabular cup. This is a drawback
in patients with compromised bone quality and might require cement fixation. In a recent
study, Sunilkumar et al. highlighted the risk of improper cup fixation and periprosthetic
acetabular fractures with the use of DMCs for FNF in elderly patients [49]. The lack of
screws for fixation and the inability to visualize the acetabular floor during impaction were
considered disadvantages of this implant, particularly in presence of osteoporotic bones.
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5. Conclusions
In the past decades, concerns have been raised for the long-term survival of first-
generation DMCs, since the additional bearing surface could accelerate polyethylene wear
and increase the risk of aseptic loosening [50]. However, recent register studies comparing
DMC and conventional THA have ruled out these concerns, reporting no differences in
revision rates for loosening with newer implants [17,25].
Despite that our study was limited by a small sample size, according to our experience
and to the most recent literature on the topic, we conclude that DMC THA presents short-
term outcomes comparable to conventional THA. The use of DMCs for the treatment of
displaced FNF in older patients is a reasonable choice, since it allows for a decrease in
the risk of postoperative dislocations and improves the prognosis of these frail and often
non-cooperative subjects.
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